01093 CSPC PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.27X | Oper Margin | 19.7% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 14.9% |
| Total Debt/Equity | 1.6% | Return on Equity | 13.4% |
| Price/Book | 3.05X | Return on Assets | 9.8% |
| (HKD 9.000) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 4,602.87 | 6,473.58 | 6,829.67 | 6,855.70 | 6,123.48 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -28.9 | -5.2 | -0.4 | +12.0 | +47.5 |
| Earnings Per Share (HKD) | 0.392 | 0.545 | 0.573 | 0.574 | 0.512 |
| Earnings Per Share Growth (%) | -28.1 | -4.9 | -0.1 | +12.0 | +47.5 |
| Dividend Per Share (HKD) | 0.260 | 0.280 | 0.210 | 0.180 | 0.128 |
| P/E* (X) | 22.95 | 16.50 | 15.70 | 15.69 | 17.57 |
| Yield (%) | 2.89 | 3.11 | 2.33 | 2.00 | 1.42 |
| Dividend Share (%) | 66.31 | 51.35 | 36.64 | 31.39 | 24.89 |
| Book NAV (HKD) | 2.948 | 3.075 | 2.837 | 2.660 | 2.214 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-21 21:40:20
Latest Result
| (RMBMn) | 2025-03 | 2024-03 | Chg* (%) | 2023-03 |
| Cover Period (mths) | 3 | 3 | NA | 3 |
|---|---|---|---|---|
| Turnover | 7,015 | 8,983 | -21.9 | 8,053 |
| Operating Result | 1,786 | 2,087 | -14.4 | 1,798 |
| Associates | 10.167 | -28.493 | -135.7 | -16.737 |
| Profit Before Taxation | 1,796 | 2,058 | -12.7 | 1,781 |
| Taxation | 301.258 | 428.35 | -29.7 | 311.861 |
| Profit /( Loss) After Taxation | 1,495 | 1,630 | -8.3 | 1,469 |
| Minority Interests | 16.81 | 17.037 | -1.3 | 40.257 |
| Net Profit | 1,478 | 1,613 | -8.4 | 1,429 |
| Earnings Per Share () | 0.1385 | 0.1474 | -6.0 | 0.1370 |
| Announcement Date | 2025-05-29 | 2024-05-27 | NA | 2023-05-25 |
* Annualised
Last Update Time: 2025-07-21 21:40:25
